GlassScriptPhysician profile
Fareed Dosani
NPI 1366176091
$6,103.84
in general payments reported to CMS, 2019-2025
17 companies · $2,021 in 2025
The $2,021 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,393 · 2023: $1,638 · 2024: $1,052 · 2025: $2,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,281 · Entertainment: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,280.62 |
| Entertainment | $430.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,493.39 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,020.00 | 2022-2025 | Acuvue |
| Alcon Vision LLC | $510.21 | 2022-2025 | Precision7, Total30, Rocklatan |
| Bausch & Lomb Americas INC. | $458.40 | 2022-2025 | Infuse, Vyzulta, Prolensa |
| Optos, INC. | $430.55 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $336.91 | 2023 | Tyrvaya |
| Dompe US, INC. | $318.97 | 2022-2024 | Oxervate |
| Sight Sciences, INC. | $282.41 | 2022-2023 | Omni Surgical System |
| Glaukos Corporation | $280.70 | 2023-2025 | Photrexa Viscous and Photrexa |
| Tarsus Pharmaceuticals, INC. | $248.07 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $245.66 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $164.67 | 2022-2023 | Cequa |
| Amgen INC. | $134.93 | 2025 | Tepezza |
| Rxsight INC | $76.26 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Horizon Therapeutics Plc | $53.25 | 2023 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $26.55 | 2023 | |
| Novartis Pharmaceuticals Corporation | $22.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fareed Dosani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.